Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030
- Tuesday, December 6, 2022, 7:04
- Finance
- Add a comment
Delivers new drug for two consecutive years by obtaining product license on “Envlo”, Korea’s 36th new drug from the Ministry of Food and Drug Safety Plans to enter the type 2 diabetes global market worth $71.4 billion Provides new and broad treatment options for patients with insufficient…
About the Author
adminasapcorp has written 41297 stories on this site.